Skip to content
OpenCapital
Get started

Exagen Inc. XGN Finance Lease Liability, Current

Finance Lease Liability, Current at other companies

Labcorp Holdings logo
Labcorp HoldingsLH
$4.6M-4.2%
Bio-Rad Laboratories logo
Bio-Rad LaboratoriesBIO
$500K0.0%
Aurinia Pharmaceuticals logo
Aurinia PharmaceuticalsAUPH
$16.52M+13.9%

Other financials

Income statement

See full
Revenue$17.3M+11.7%
Gross profit$10.2M+11.9%
Operating income-$3.4M-1.5%
Net income-$4.0M-5.7%
EPS (diluted)-$0.17+15.0%

Balance sheet

See full
Cash & equivalents$21.7M+90.6%
Total debt$27.1M+15.8%
Total equity$14.4M+125%
Total assets$52.0M+28.9%

Cash flow

See full
Operating cash flow-$10.4M+2.4%
CapEx$228.0K+102%
Free cash flow-$10.6M+1.3%

Valuation

See full
Market cap$112.34M-26.5%
Enterprise value$117.78M-20.3%
P/S1.6×-1.0×

Profitability

See full
Gross margin58.3%-1.0pp
Operating margin-20.6%-2.9pp
Net margin-29.5%+2.5pp
FCF margin-27.5%—

Returns & leverage

See full
Return on equity-193.6%+355pp
Debt / equity1.9×-1.8×
Current ratio3.5×+1.1×

Where this comes from

Reported directly by Exagen Inc. in its filing.

Tagged under the XBRL concept us-gaap:FinanceLeaseLiabilityCurrent.

The official record: Exagen Inc.’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about Exagen Inc.'s finance lease liability, current.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Exagen Inc.'s finance lease liability, current?
Exagen Inc. (XGN) reported finance lease liability, current of $1.11M in Q1 2026.
What is the long-term trend for Exagen Inc.'s finance lease liability, current?
Over 5 years (2020 to 2025), Exagen Inc.'s finance lease liability, current has grown at a 27.0% compound annual growth rate (CAGR), from $344K to $1.14M.
What does finance lease liability, current mean?
Finance lease liabilities (current) represent the portion of lease obligations that are due to be paid within the next twelve months. These obligations arise from long-term contracts where the company effectively controls the leased asset. This metric is critical for assessing near-term liquidity and cash flow requirements.